Research graph
References from Outcomes of lung transplantation from donors with hepatitis C viremia with outpatient initiation of antiviral therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Trends in use and three-year outcomes of hepatitis C virus-viremic donor lung transplants for hepatitis C virus-seronegative recipients
10.1016/j.jtcvs.2022.08.019 · 2023 · External reference
Donor and recipient hepatitis C status does not affect rejection in thoracic transplantation
10.1016/j.athoracsur.2022.05.072 · 2023 · External reference
Outcomes of lung transplantation from hepatitis C viremic donors
10.1016/j.athoracsur.2021.05.010 · 2022 · External reference
Heart and lung transplants from HCV-infected donors to uninfected recipients
10.1056/nejmoa1812406 · 2019 · External reference
One-year immunologic outcomes of lung transplantation utilizing hepatitis C-viremic donors
10.1111/ctr.14749 · 2022 · External reference
Impact of early initiation of direct-acting antiviral therapy in thoracic organ transplantation from hepatitis C virus positive donors
10.1053/j.semtcvs.2020.06.045 · 2021 · External reference
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study
10.1016/s2468-1253(20)30081-9 · 2020 · External reference
Increasing access to thoracic organs from donors infected with hepatitis C: a previous challenge-now an opportunity
10.1016/j.healun.2017.05.028 · 2018 · External reference
Treading lightly as we step into a new era: Use of hepatitis C virus-infected organs for transplantation
10.1016/j.jtcvs.2019.05.091 · 2020 · External reference
Treatment of hepatitis C in a lung transplant recipient with sofosbuvir and daclatasvir
10.1016/j.healun.2016.01.1219 · 2016 · External reference
Successful lung transplantation from hepatitis C positive donor to seronegative recipient
10.1111/ajt.14137 · 2017 · External reference
Lung transplantation from hepatitis C viremic donors to uninfected recipients
10.1164/rccm.201712-2614le · 2018 · External reference
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial
10.1016/s2213-2600(19)30268-1 · 2020 · External reference
Increased early acute cellular rejection events in hepatitis C-positive heart transplantation
10.1016/j.healun.2020.06.022 · 2020 · External reference
Long-term follow-up of acute and chronic rejection in heart transplant recipients from hepatitis C viremic (NAT+) donors
10.1111/ajt.17190 · 2022 · External reference
Impact of donor hepatitis C viremia on acute rejection in heart transplant recipients
10.1016/j.healun.2022.01.214 · 2022 · External reference
The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes
10.21037/acs.2020.01.03 · 2020 · External reference
